… grade 3 high-risk invasive breast cancer, according to results from … [ER-positive/HER2-negative breast cancer], a significantly higher percentage of … mg m-2 of paclitaxel once weekly for the … -stage, ER+/HER2− breast cancer: a randomized phase 3 trial …

… transcription and accelerated breast cancer tumorigenesis(21). … positive breast cancer patients received trastuzumab plus paclitaxel, … of breast cancer, different subtypes of breast cancer might … methylation contributes to breast cancer tumorigenesis and drug …

… positive, HER2-ultralow metastatic breast cancer eligible for fam-trastuzumab … The rising incidence of metastatic breast cancer, particularly among younger populations, … oral capecitabine, intravenous paclitaxel, or intravenous nab-paclitaxel. The primary …

… The rising incidence of metastatic breast cancer, particularly among younger populations … comprising capecitabine, nab-paclitaxel (Abraxane), or paclitaxel. Stratification factors included … with HER2-ultralow metastatic breast cancer eligible for Enhertu. News …

… of highly malignant breast cancers, including TNBC, … breast cancer cells under both static and dynamic conditions. Moreover, paclitaxel … treatment of malignant breast tumors, the key … breast tumours using ultrasound responsive microbubbles loaded with paclitaxel …

… breast tumor treatment.66,67 Therefore, nanoparticle-based combination therapies represent promising breast cancer … to other cancers, breast tumors are often characterized by … paclitaxel in combination with alpha-PD1 induces tumor remission of breast cancer …

… For endocrine-susceptible breast cancers, the next line … cycles of chemotherapy (paclitaxel or vinorelbine) with … metastatic breast cancer. Presented at: San Antonio Breast Cancer Symposium; … metastatic breast cancer: phase 1b study. NPJ Breast Cancer. 2022; …

… combination with chemotherapy (carboplatin and paclitaxel) followed by Imfinzi monotherapy in … with SCLC, NSCLC, bladder cancer, breast cancer, several gastrointestinal and gynaecologic cancers …

… combination with Trastuzumab, Ramucirumab, and Paclitaxel for the treatment of HER2 … Solid Cancers 5.1.1 Breast Cancer 5.1.2 Colorectal Cancer …

… and Soluble Signals Regulate Breast Cancer Metastatic Dormancy. Current … and prevents human breast cancer-induced bone loss … receptor inhibitor, and paclitaxel in patients with advanced … strategies driving immunotherapy in breast cancer treatment: a real …